Prof. Mike Chan Opens PreventMed 2026 with a Call for Precision Stem Cell Medicine

Malaysian Regenerative Medicine Pioneer Presents Vision for the Future at Russia’s Leading Preventive Medicine Forum

MOSCOW, Russia (June 24, 2026) — The future of regenerative medicine will not be shaped by one-size-fits-all therapies but by precision, personalization, and prevention.

That was the central message delivered by Prof. Dato’ Sri Dr. Mike Chan, Chairman and Founder of the European Wellness Biomedical Group, as he opened his two-day scientific program at PreventMed 2026, one of Russia’s premier international forums dedicated to preventive medicine, healthy longevity, and biomedical innovation.

Invited by the National Medical Research Center for Therapy and Preventive Medicine under the Ministry of Health of the Russian Federation, Prof. Mike Chan presented his keynote during the II International Conference “Cellular Technologies and Regenerative Medicine: A Look into the Future,” held at the Physics Hall inside Moscow’s prestigious Lomonosov Cluster.

His presentation, “Precision in Stem Cells in Preventive, Regenerative & Longevity,” drew physicians, researchers, clinicians, and healthcare innovators from around the world eager to explore the next generation of regenerative medicine.

Conference Exhibition & Registration: Healthcare professionals and international delegates arrive at the Lomonosov Cluster and explore the PreventMed 2026 exhibition, where leading biomedical companies showcased the latest advances in preventive medicine, regenerative therapies, diagnostics, and healthy ageing technologies.

Precision Is Replacing One-Size-Fits-All Medicine

Opening his presentation, Prof. Mike Chan challenged the traditional perception of stem cell therapy, explaining that tomorrow’s regenerative medicine will depend not on giving more stem cells but on delivering the correct cells to the correct organs.

Interactive Keynote: An international audience of physicians, researchers, and healthcare professionals engaged closely as Prof. Mike Chan presented scientific insights into targeted stem cell technologies, preventive medicine, and the future of personalized regenerative healthcare.

“Precision changes everything. The future is no longer about giving more stem cells—it is about delivering the right cells to the right organ, at the right stage of degeneration. That is where regenerative medicine is heading,” he said.

Drawing on more than four decades of regenerative medicine research, Prof. Mike Chan explained that every organ possesses its own biological identity, requiring targeted cellular support rather than generalized treatment.

“The brain is different from the pancreas. The kidneys are different from the liver. Every organ has its own cellular language. When medicine begins respecting that biological precision, regenerative therapy becomes far more intelligent.”

Healthspan—Not Simply Lifespan

Throughout the session, Prof. Chan reinforced one philosophy that has become synonymous with his life’s work.

“Living longer is no longer the challenge. Living healthier is. My goal has always been to help people extend their healthspan so they can enjoy every additional year of life.”

He explained that modern medicine should no longer focus solely on extending years of life but on preserving brain function, organ performance, mobility, independence, and overall quality of life.

Instead of waiting for disease to develop, physicians should intervene much earlier—identifying biological decline before symptoms emerge and restoring function through precision diagnostics and regenerative medicine.

“It is always easier to preserve function than to recover it after years of deterioration.”

Building the Future of Preventive Medicine

Prof. Mike Chan also explored how advances in cellular biology, artificial intelligence, biological mapping, and precision diagnostics are transforming preventive healthcare.

He outlined a future where clinicians will increasingly predict biological decline before disease develops, allowing targeted interventions that maintain healthy organs rather than simply treating illness after it appears.

This philosophy reflects European Wellness’ proprietary DDRR (Diagnose, Detox, Repair, and Rejuvenate) framework, which integrates advanced diagnostics, detoxification, regenerative therapies, and personalized longevity programs into a comprehensive preventive medicine model. The approach includes precision diagnostics such as OG Scan, hyperbaric oxygen therapy, targeted organ-specific precursor stem cells, MO/NOP peptide support, and executive biohacking programs.

European Wellness Showcases Its Biomedical Innovations

Beyond the lecture theater, European Wellness Biomedical Group welcomed delegates to its exhibition booth, where clinicians and healthcare professionals explored the company’s latest developments in regenerative medicine and healthy aging.

Visitors learned about European Wellness’ targeted organ-specific precursor stem cell therapies, precision diagnostic technologies, peptide bioregulation, regenerative rehabilitation programs, and executive longevity solutions while exchanging ideas on the future of preventive healthcare.

Throughout the exhibition, the booth became an active hub for scientific discussions, professional networking, and potential international collaborations.

Conversations Continued Long After the Lecture

While the official session concluded at 12.20 pm, the scientific discussion was far from over.

Doctors, researchers, and clinicians gathered around Prof. Chan immediately after the presentation, continuing conversations on precision regenerative medicine, organ-specific therapies, and future clinical applications for well over an hour.

The spontaneous gathering reflected the growing international interest in personalized regenerative medicine and demonstrated how rapidly the field continues to evolve.

“Science belongs to humanity. When doctors and researchers share knowledge across borders, patients everywhere stand to benefit. That is how preventive medicine moves forward,” Prof. Chan said.

Post-Lecture Interaction: Delegates surround Prof. Chan after the session, seeking further discussion on stem cell science, peptide bioregulation, and personalized longevity medicine.